Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Bilal Abid

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Clinical Case Reports|February 16, 2018
Endovascular clot retrieval in extensive cerebral venous sinus thrombosis (CVST): a videographic reportMuhammad Bilal Abid, Vijay Kumar Sharma
Infection|September 4, 2019
Probiotics in health and disease: fooling Mother Nature?Muhammad Bilal Abid, Calvin J Koh
Hematological Oncology|December 15, 2021
SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: A systematic review and preliminary observationsMuhammad Abbas Abid, Muhammad Bilal Abid
Lancet (London, England)|June 18, 2023
Climate change justice goes beyond authorship equityMuhammad Abbas Abid, Muhammad Bilal Abid
Transplantation and Cellular Therapy|August 13, 2025
From Risk to Reach: How REMS Remediation Will Shape CAR-T AccessMuhammad Bilal Abid, Noufil Adnan, Nausheen Ahmed
WMJ : Official Publication of the State Medical Society of Wisconsin|July 26, 2023
An Unlikely Guest With an Overstayed Welcome: <i>Cyclospora</i>-Induced Postinfectious Irritable Bowel SyndromeMatthew Aiken, Trisha Jethwa, Muhammad Bilal Abid
British Journal of Haematology|June 8, 2026
Cost-effective analysis of teclistamab and daratumumab versus ciltacabtagene autoleucel in relapsed multiple myelomaSohaib Irfan, M Abdullah Jamil, Muhammad Bilal Abid
JAMA Oncology|May 21, 2020
Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer TreatmentMuhammad Bilal Abid, Mustafa Mughal, Muhammad Abbas Abid
Singapore Medical Journal|May 25, 2017
Anaemia with Laugier-Hunziker Syndrome: a diagnostic dilemmaMuhammad Bilal Abid, Paras Mughal, Muhammad Abbas Abid
Frontiers in Immunology|June 26, 2020
Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic PipelineMuhammad Abbas Abid, Loren Nunley, Muhammad Bilal Abid
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Clinical Case Reports|February 16, 2018
Endovascular clot retrieval in extensive cerebral venous sinus thrombosis (CVST): a videographic reportMuhammad Bilal Abid, Vijay Kumar Sharma
Infection|September 4, 2019
Probiotics in health and disease: fooling Mother Nature?Muhammad Bilal Abid, Calvin J Koh
Hematological Oncology|December 15, 2021
SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: A systematic review and preliminary observationsMuhammad Abbas Abid, Muhammad Bilal Abid
Lancet (London, England)|June 18, 2023
Climate change justice goes beyond authorship equityMuhammad Abbas Abid, Muhammad Bilal Abid
Transplantation and Cellular Therapy|August 13, 2025
From Risk to Reach: How REMS Remediation Will Shape CAR-T AccessMuhammad Bilal Abid, Noufil Adnan, Nausheen Ahmed
WMJ : Official Publication of the State Medical Society of Wisconsin|July 26, 2023
An Unlikely Guest With an Overstayed Welcome: <i>Cyclospora</i>-Induced Postinfectious Irritable Bowel SyndromeMatthew Aiken, Trisha Jethwa, Muhammad Bilal Abid
British Journal of Haematology|June 8, 2026
Cost-effective analysis of teclistamab and daratumumab versus ciltacabtagene autoleucel in relapsed multiple myelomaSohaib Irfan, M Abdullah Jamil, Muhammad Bilal Abid
JAMA Oncology|May 21, 2020
Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer TreatmentMuhammad Bilal Abid, Mustafa Mughal, Muhammad Abbas Abid
Singapore Medical Journal|May 25, 2017
Anaemia with Laugier-Hunziker Syndrome: a diagnostic dilemmaMuhammad Bilal Abid, Paras Mughal, Muhammad Abbas Abid
Frontiers in Immunology|June 26, 2020
Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic PipelineMuhammad Abbas Abid, Loren Nunley, Muhammad Bilal Abid
Pageof 11